Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%?40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection. Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
Market Analysis and Insights: Global Neurosyphilis Market The global Neurosyphilis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurosyphilis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurosyphilis market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurosyphilis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurosyphilis market.
Global Neurosyphilis Scope and Market Size Neurosyphilis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurosyphilis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6468770/global-neurosyphilis-2021-2027-790
Segment by Type Asymptomatic Neurosyphilis Meningeal Neurosyphilis Meningovascular Neurosyphilis Others
Segment by Application Hospital & Clinics Medical Research Centers Academic Institutes
By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
By Company Abbott Bayer Eli Lilly and Company GlaxoSmithKline Novartis Pfizer Sanofi
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-neurosyphilis-2021-2027-790-6468770
Table of content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurosyphilis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Asymptomatic Neurosyphilis
1.2.3 Meningeal Neurosyphilis
1.2.4 Meningovascular Neurosyphilis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurosyphilis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Medical Research Centers
1.3.4 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neurosyphilis Market Perspective (2016-2027)
2.2 Neurosyphilis Growth Trends by Regions
2.2.1 Neurosyphilis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurosyphilis Historic Market Share by Regions (2016-2021)
2.2.3 Neurosyphilis Forecasted Market Size by Regions (2022-2027)
2.3 Neurosyphilis Industry Dynamic
2.3.1 Neurosyphilis Market Trends
2.3.2 Neurosyphilis Market Drivers
2.3.3 Neurosyphilis Market Challenges
2.3.4 Neurosyphilis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurosyphilis Players by Revenue
3.1.1 Global Top Neurosyphilis Players by Revenue (2016-2021)
3.1.2 Global Neurosyphilis Revenue Market Share by Players (2016-2021)
3.2 Global Neurosyphilis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
CONTACT US:
New York City Zone 01, United States
International: (+1) 646 781 7170
Email:
[email protected]